The coronavirus pandemic continues to impact the everyday lives of people across the world, but as vaccines become more widely available there is hope that COVID-19 could be under control in a matter of months.
Johnson & Johnson is going to do its part in sharing vaccines with a plan to have 100 million vaccines available in the United States by April.
Dr. Mark McClellan, a J&J board member and former Food and Drug Administration commissioner shared the news that the company is “going all out” with their production of the vaccine.
“I do know that J&J is making a very large supply … with the goal of having perhaps enough vaccines for 100 million Americans by spring, by this April or so,” McClellan told CNBC Thursday evening. “That’s going to make a big difference in supply availability over the coming weeks and months if the trial does work out.”
So far, less than half of the 38 million doses of other vaccines that were distributed have been administered.
The coronavirus mainly comes from animals and a majority of those who were infected early either worked at or frequently visited the Huanan seafood wholesale market in Wuhan, according to The Guardian. The virus is similar to Severe acute respiratory syndrome (Sars) and Middle Eastern respiratory syndrome (Mers).
The Wuhan coronavirus is transmitted from person to person through “droplet transmission.” That means an infected person can pass the virus by sneezing or coughing on another person as well as by direct contact.
While a majority of the cases have been detected in the United States and China — with more than 24.7 million confirmed cases and 410,000 deaths in the United States — it has now reached many countries around the world. It has also been confirmed in Italy, Australia, Canada, France, Germany, and many other eastern countries.